Hassoun, EA; Li, F.; Abushaban, A.; Stohs, SJ. The relative abilities of TCDD and its congeners to induce oxidative stress in the hepatic and brain tissues of rats after subchronic exposure. Toxicology. 2000, APR 14. 145(2-3):103-113.

Hilleman, DE. Role of angiotensin-converting-enzyme inhibitors in the treatment of hypertension. American Journal of Health-System Pharmacy. 2000, OCT 1. 57(19):S8-S11.

Hilleman, DE; Dewan, N.; Malesker, M.; Friedman, M. Pharmacoeconomic evaluation of COPD. Chest. 2000, NOV. 118(5):1278-1285.

Hilleman, DE. New approaches to the management of AMI: Fibrinolysis plus GP IIb/IIIa receptor blockade. Formulary. 2000, SEP. 35(9):738-751.

Faulkner, MA; Wadibia, EC; Lucas, BD; Hilleman, DE. Impact of pharmacy counseling on compliance and effectiveness of combination lipid-lowering therapy in patients undergoing coronary artery revascularization: A randomized, controlled trial. Pharmacotherapy. 2000, APR. 20(4):410-416.

Haddad, A. Fortresses and formularies: response 1. American Journal of Health-System Pharmacy. 2000, MAY. 57(9):856-857.

Graham, J.; Awe, SO; LeDay, AM; Rice, JC; Ramos, G.; Harris, LC; Opere, CA; Ohia, SE. Effect of inhibition of cyclooxygenase on pre- and postjunctional actions of peroxides in the iris-ciliary body. Neurochemical research. 2000, APR. 25(4):519-525.

Awe, SO; Opere, CA; Harris, LC; Uketui, AJ; Ohia, SE. Effect of isoprostanes on sympathetic neurotransmission in the human isolated iris-ciliary body. Neurochemical research. 2000, APR. 25(4):491-496.

Jensen, GM; Gwyer, J.; Shepard, KF; Hack, LM. Competence and complacency - Author response. Physical Therapy. 2000, MAY. 80(5):531.

Jensen, GM; Gwyer, J.; Shepard, KF; Hack, LM. Expert practice in physical therapy. Physical Therapy. 2000, JAN. 80(1):28-43.